Health Care & Life Sciences » Biotechnology | Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp. | Balance Sheet

Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
138.40
765.00
876.30
94.80
190.30
185.40
Other Current Assets
12.00
106.90
20.40
27.70
10.60
36
Total Current Assets
150.50
871.90
896.70
122.60
200.90
221.40
Net Property, Plant & Equipment
78.10
61.70
51.60
36.20
24.30
17.70
Total Assets
228.60
933.60
948.30
158.80
225.20
239.10
ST Debt & Current Portion LT Debt
145.50
154.10
184.10
184.60
348.80
Accounts Payable
277.00
166.00
-
-
-
Other Current Liabilities
18.80
236.70
503.50
522.60
716.10
Total Current Liabilities
441.30
556.80
687.60
707.10
1,065.00
Other Liabilities
531.30
818.70
-
86.90
147.20
Total Liabilities
972.60
1,375.50
687.60
794.10
1,212.20
Common Equity (Total)
30.20
617.30
2,150.20
1,512.40
905.40
Total Shareholders' Equity
30.20
617.30
2,150.20
1,512.40
905.40
Total Equity
744.00
442.00
260.70
635.30
987.00
Liabilities & Shareholders' Equity
228.60
933.60
948.30
158.80
225.20
Accumulated Minority Interest
774.10
1,059.30
1,889.50
2,147.70
1,892.40

About Advanced Proteome Therapeutics

View Profile
Address
BioSquare
Boston Massachusetts 02118
United States
Employees -
Website http://www.advancedproteome.com
Updated 07/08/2019
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development of anti-cancer therapeutics. It also commercializes technology platform that is intended for the chemical modification of protein therapeutics. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Boston, MA.